(Q44051982)

29 November 2017

title

Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study (English)

1 reference

29 November 2017

0 references

1 reference

4

1 reference

29 November 2017

6

1 reference

29 November 2017

Hillbom M

1

1 reference

29 November 2017

Erilä T

series ordinal

2

1 reference

29 November 2017

Sotaniemi K

series ordinal

3

1 reference

29 November 2017

Sarna S

series ordinal

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Acta Neurologica Scandinavica

29 November 2017

published in

1 reference

29 November 2017

volume

106

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

84-92

1 reference

Complications after acute stroke

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Identification of candidates for prevention of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

The prevalence of risk factors for venous thromboembolism among hospital patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Components of coagulation and fibrinolysis during thrombosis prophylaxis with a low molecular weight heparin (Enoxaparin) versus Dextran 70 in hip arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Low molecular weight heparin in prevention of perioperative thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Low-molecular-weight heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Cost-effectiveness of venous thrombosis prophylaxis following ischemic stroke: an assessment of currently available literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

Prophylaxis of venous thromboembolism in stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

7 January 2021

Autopsy-verified causes of death after stroke

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

7 January 2021

[Prevention of venous thrombosis in recent ischaemic cerebrovascular accident: double-blind study with heparin-dihydroergotamine (author's transl)]

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

7 January 2021

Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

7 January 2021

Roentgen diagnosis of venous thrombosis in the leg

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

7 January 2021

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

7 January 2021

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

7 January 2021

Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. A comparison between unfractionated and low-molecular-weight heparin.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01215.X

7 January 2021

10.1034/J.1600-0404.2002.01215.X

Identifiers

DOI

1 reference

29 November 2017

1 reference